Clinical Trial Update: Monoclonal Antibody Therapy or Biological Therapy in Treating Patients With Chronic Lymphocytic Leukemia or Multiple Myeloma in Remission After Chemotherapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating monoclonal antibody therapy or biological therapy in patients with chronic lymphocytic leukemia or multiple myeloma in remis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Multiple Myeloma

Drugs mentioned

• Monoclonal antibody therapy (unspecified)

Snippet

Sponsor: Hoag Memorial Hospital Presbyterian | Conditions: Leukemia, Multiple Myeloma and Plasma Cell Neoplasm | Phase 2 | Status: WITHDRAWN